70 related articles for article (PubMed ID: 9544675)
1. Fluorine-18-fluorodeoxyglucose dual-head gamma camera coincidence imaging of recurrent colorectal carcinoma.
Abdel-Dayem HM; Radin AI; Luo JQ; Marans HY; Wong S; Naddaf SY; El-Zeftawy HM; Omar WS; Mithilesh K; Abujudeh H; Atay S
J Nucl Med; 1998 Apr; 39(4):654-6. PubMed ID: 9544675
[TBL] [Abstract][Full Text] [Related]
2. Role of (18)F-FDG dual-head gamma-camera coincidence imaging in recurrent or metastatic colorectal carcinoma.
Even-Sapir E; Lerman H; Figer A; Rabau M; Livshitz G; Inbar M; Gutman M
J Nucl Med; 2002 May; 43(5):603-9. PubMed ID: 11994521
[TBL] [Abstract][Full Text] [Related]
3. Comparison of dual-head coincidence gamma camera FDG imaging with FDG PET in detection of breast cancer and axillary lymph node metastasis.
Yutani K; Tatsumi M; Shiba E; Kusuoka H; Nishimura T
J Nucl Med; 1999 Jun; 40(6):1003-8. PubMed ID: 10452318
[TBL] [Abstract][Full Text] [Related]
4. Oncologic diagnosis with 2-[fluorine-18]fluoro-2-deoxy-D-glucose imaging: dual-head coincidence gamma camera versus positron emission tomographic scanner.
Shreve PD; Steventon RS; Deters EC; Kison PV; Gross MD; Wahl RL
Radiology; 1998 May; 207(2):431-7. PubMed ID: 9577492
[TBL] [Abstract][Full Text] [Related]
5. Positron emission tomography and colorectal carcinoma: an update.
Tzimas GN; Koumanis DJ; Meterissian S
J Am Coll Surg; 2004 Apr; 198(4):645-52. PubMed ID: 15051018
[No Abstract] [Full Text] [Related]
6. The clinical application of a dual head gamma camera with coincidence detection in 20 women with suspected ovarian cancer.
Lieberman G; MacLean AB; Buscombe JR; Hilson AJ; Adamson K; Reid WM; Green A; Begent RH
BJOG; 2001 Dec; 108(12):1229-36. PubMed ID: 11843384
[TBL] [Abstract][Full Text] [Related]
7. Detection of recurrent colorectal carcinoma by 18F-FDG: comparison of the clinical performances of FDG PET and FDG CDET.
Montravers F; Grahek D; Kerrou K; Younsi N; Petegnief Y; de Beco V; Colombet-Lamau C; Talbot JN
Nucl Med Commun; 2004 Feb; 25(2):105-13. PubMed ID: 15154697
[TBL] [Abstract][Full Text] [Related]
8. Paraganglioma seen with FDG dual-head gamma camera coincidence imaging after false-negative results of I-123 MIBG imaging.
Fukuchi K; Inenaga T; Suzuki Y; Horita Y; Hayashida K; Ishida Y
Clin Nucl Med; 2001 Nov; 26(11):966-7. PubMed ID: 11595866
[No Abstract] [Full Text] [Related]
9. Feasibility of fluorodeoxyglucose dual-head gamma camera coincidence imaging in the evaluation of lung cancer: comparison with FDG PET.
Tatsumi M; Yutani K; Watanabe Y; Miyoshi S; Tomiyama N; Johkoh T; Kusuoka H; Nakamura H; Nishimura T
J Nucl Med; 1999 Apr; 40(4):566-73. PubMed ID: 10210214
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of spine metastases by FDG imaging using a gamma camera in the coincidence mode.
Shreve PD; Steventon RS; Gross MD
Clin Nucl Med; 1998 Dec; 23(12):799-802. PubMed ID: 9858288
[TBL] [Abstract][Full Text] [Related]
11. Colorectal cancer. Radiologic staging.
Thoeni RF
Radiol Clin North Am; 1997 Mar; 35(2):457-85. PubMed ID: 9087214
[TBL] [Abstract][Full Text] [Related]
12. Fluorine-18-FDG detection of laryngeal cancer postradiotherapy using dual-head coincidence imaging.
Stokkel MP; Terhaard CH; Mertens IJ; Hordijk GJ; van Rijk PP
J Nucl Med; 1998 Aug; 39(8):1385-7. PubMed ID: 9708513
[TBL] [Abstract][Full Text] [Related]
13. F-18 FDG uptake by recurrent Hürthle cell carcinoma of the thyroid using high-energy planar scintigraphy.
Blount CL; Dworkin HJ
Clin Nucl Med; 1996 Nov; 21(11):831-3. PubMed ID: 8922841
[TBL] [Abstract][Full Text] [Related]
14. 18F-FDG PET/CT delayed images after diuretic for restaging invasive bladder cancer.
Anjos DA; Etchebehere EC; Ramos CD; Santos AO; Albertotti C; Camargo EE
J Nucl Med; 2007 May; 48(5):764-70. PubMed ID: 17475965
[TBL] [Abstract][Full Text] [Related]
15. Value of combined FDG PET and MR imaging in the evaluation of suspected recurrent local-regional breast cancer: preliminary experience.
Hathaway PB; Mankoff DA; Maravilla KR; Austin-Seymour MM; Ellis GK; Gralow JR; Cortese AA; Hayes CE; Moe RE
Radiology; 1999 Mar; 210(3):807-14. PubMed ID: 10207485
[TBL] [Abstract][Full Text] [Related]
16. 18F-FDG PET/CT in a patient with lymph node metastasis from ovarian adenocarcinoma.
Gontier E; Wartski M; Guinebretiere JM; Alberini JL
AJR Am J Roentgenol; 2006 Sep; 187(3):W285-9. PubMed ID: 16928906
[No Abstract] [Full Text] [Related]
17. Image fusion using an integrated, dual-head coincidence camera with X-ray tube-based attenuation maps.
Patton JA; Delbeke D; Sandler MP
J Nucl Med; 2000 Aug; 41(8):1364-8. PubMed ID: 10945529
[TBL] [Abstract][Full Text] [Related]
18. Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings.
Abdel-Nabi H; Doerr RJ; Lamonica DM; Cronin VR; Galantowicz PJ; Carbone GM; Spaulding MB
Radiology; 1998 Mar; 206(3):755-60. PubMed ID: 9494497
[TBL] [Abstract][Full Text] [Related]
19. Assessment of pulmonary lesions with 18F-fluorodeoxyglucose positron imaging using coincidence mode gamma cameras.
Weber W; Young C; Abdel-Dayem HM; Sfakianakis G; Weir GJ; Swaney CM; Gates M; Stokkel MP; Parker A; Hines H; Khanvali B; Liebig JR; Leung AN; Sollitto R; Caputo G; Wagner HN
J Nucl Med; 1999 Apr; 40(4):574-8. PubMed ID: 10210215
[TBL] [Abstract][Full Text] [Related]
20. Staging recurrent metastatic colorectal carcinoma with PET.
Delbeke D; Vitola JV; Sandler MP; Arildsen RC; Powers TA; Wright JK; Chapman WC; Pinson CW
J Nucl Med; 1997 Aug; 38(8):1196-201. PubMed ID: 9255148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
